Showing results (101-110 of 117) with videos related to
Sort By:
Pageof 12
Acta Physiologica (Oxford, England)|June 1, 2006
Thyrotropin-releasing hormone in rat heart: effect of swelling, angiotensin II and renin geneZ Bacova, L Baqi, O Benacka, et al.Bratislavske Lekarske Listy|December 17, 2013
Effect of growth hormone on bone status in growth hormone-deficient adultsM Kuzma, Z Homerova, A Dlesk, et al.Physiological Research|December 18, 2019
Pathophysiology and risk factors for cholelithiasis in patients with Crohn's diseaseI Sturdik, A Krajcovicova, Y Jalali, et al.Vnitrni Lekarstvi|May 10, 2001
[Effect of alendronate therapy on bone turnover--results of a multicenter study]J Payer, Z Killinger, P Masaryk, et al.Physiological Research|December 17, 2021
The Severity of Muscle Performance Deterioration in Sarcopenia Correlates With Circulating Muscle Tissue-Specific miRNAsS Valášková, A Gažová, P Vrbová, et al.Physiological Research|May 3, 2022
The Severity of Muscle Performance Deterioration in Sarcopenia Correlates With Circulating Muscle Tissue-Specific miRNAsS Valášková, A Gažová, P Vrbová, et al.Bratislavske Lekarske Listy|July 16, 2004
Separation of Siamese twins in BratislavaJ Siman, J Payer, M Brozman, et al.Bratislavske Lekarske Listy|February 1, 1989
[Results of using high porosity aortofemoral bifurcation prostheses]J Rozhold, V Rudolf, J Stratinský, et al.Physiological Research|May 3, 2022
3D Echocardiography - A Useful Method for Cardiovascular Risk Assessment in End-Stage Renal Disease PatientsM Kovářová, Z Žilinská, J Páleš, et al.Physiological Research|December 17, 2021
3D Echocardiography - A Useful Method for Cardiovascular Risk Assessment in End-Stage Renal Disease PatientsM Kovářová, Z Žilinská, J Páleš, et al.Pageof 12